Monsanto Completes Expansion of Jerseyville Facility, Home of World's First Biotechnolgy Field Trial
The Jerseyville facility manages biotechnology field trials for projects in Monsanto’s research-and-development pipeline like dicamba-tolerant soybeans, water use efficiency cotton, nitrogen use efficiency corn, Roundup Ready 2 Yield soybeans and drought tolerant corn. The site also processes seed for further field trials in other Midwestern states. The completion of the $3 million investment creates a new office building for the location and a state-of-the-art seed processing facility.
“This expansion solidifies Jerseyville’s role as a center of biotechnology for the globe,” said Steve Padgette, Monsanto's vice president of biotechnology. “The work done at this historic facility is a key part in our R&D process. As someone who was involved in the beginning of biotechnology there, it’s personally rewarding to continue our investment in the Jerseyville facility and, subsequently, the Jerseyville community.”
The expansion includes roughly 22,000 square feet of new building or renovation, adding to the site’s existing 16 greenhouses, and nearly 300 acres of field trials. The site intends to plant roughly 120,000 field plots next summer, with about 90,000 of those to corn trials and the remainder to soybean trials.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.